ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs MXN
18.52005
-0.09%
Brent Oil
83.595
-0.36%
Bitcoin
65,485.68
-1.50%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Genocea Biosciences Inc (GNCA)

  7. Genocea Biosciences Inc (GNCA) Noticias

GNCA

Genocea Biosciences (GNCA)

Genocea Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GNCA
FechaHoraFuenteTítuloSímboloCompañía
13/06/202216:22Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNCAGenocea Biosciences Inc
13/06/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNCAGenocea Biosciences Inc
09/06/202215:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNCAGenocea Biosciences Inc
06/06/202205:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNCAGenocea Biosciences Inc
03/06/202215:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNCAGenocea Biosciences Inc
27/05/202215:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GNCAGenocea Biosciences Inc
24/05/202207:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNCAGenocea Biosciences Inc
05/05/202215:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNCAGenocea Biosciences Inc
02/05/202210:15TipRanksGenocea Biosciences (GNCA) Receives a Buy from Leerink PartnersNASDAQ:GNCAGenocea Biosciences Inc
29/04/202215:32Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:GNCAGenocea Biosciences Inc
29/04/202205:16TipRanksWhy Did H.C. Wainwright Downgrade Genocea Biosciences’ Stock?NASDAQ:GNCAGenocea Biosciences Inc
11/04/202221:09TipRanksLeerink Partners Thinks Genocea Biosciences’ Stock is Going to RecoverNASDAQ:GNCAGenocea Biosciences Inc
06/04/202205:55TipRanksGenocea Biosciences (GNCA) Gets a Buy Rating from NeedhamNASDAQ:GNCAGenocea Biosciences Inc
18/03/202215:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GNCAGenocea Biosciences Inc
18/03/202215:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNCAGenocea Biosciences Inc
16/03/202216:32Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:GNCAGenocea Biosciences Inc
11/03/202221:52TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Eiger Biopharmaceuticals (EIGR), Geron (GERN)NASDAQ:GNCAGenocea Biosciences Inc
10/03/202214:35TipRanksAnalysts Are Bullish on These Healthcare Stocks: Genocea Biosciences (GNCA), Amryt Pharma (AMYT)NASDAQ:GNCAGenocea Biosciences Inc
10/03/202209:35TipRanksH.C. Wainwright Thinks Genocea Biosciences’ Stock is Going to RecoverNASDAQ:GNCAGenocea Biosciences Inc
07/03/202215:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNCAGenocea Biosciences Inc
14/02/202215:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNCAGenocea Biosciences Inc
04/01/202213:35TipRanksNeedham Thinks Genocea Biosciences’ Stock is Going to RecoverNASDAQ:GNCAGenocea Biosciences Inc
10/05/202115:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GNCAGenocea Biosciences Inc
29/04/202106:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNCAGenocea Biosciences Inc
14/04/202115:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNCAGenocea Biosciences Inc
31/03/202106:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GNCAGenocea Biosciences Inc
28/08/202015:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GNCAGenocea Biosciences Inc
03/08/202015:44Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:GNCAGenocea Biosciences Inc
19/06/202015:05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GNCAGenocea Biosciences Inc
30/08/201907:00GlobeNewswire Inc.Genocea to Present at September Healthcare ConferencesNASDAQ:GNCAGenocea Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:GNCA

Su Consulta Reciente

NYSE
DIS
Walt Disney
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
OILBRENT
Brent Oil
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados